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INTRODUCTION 
Patients with chronic medical conditions often have to adjust their 
aspirations, lifestyle, and employment. Many grieve about their predicament 
before adjusting to it. But others have protracted distress and may develop 
psychiatric disorders, most commonly depression or anxiety. In studies with 
cancer patients, affective disorder exceeds 30%, and with rheumatoid arthritis, 
Diabetes it is between 20% and 25%, with myocardial infarction 40% - 65%, with 
cerebrovascular accident (CVA) 10% - 27 %.( Jane Turner et al. ,2000) 
 Community-based epidemiological studies conducted in India on mental 
and behavioral disorders report varying prevalence rates, ranging from 9.5 to 102 
per 1000 population.( Suresh Bada Math et al. ,2010) 
Chronic kidney disease (CKD) 
(1) CKD is emerging to be an important chronic disease globally. 10% of the 
population worldwide is affected by CKD (World Kidney Day: Chronic 
kidney Disease. 2015). According to 2010 Global Burden of Disease study, 
CKD was ranked 27th in the list of causes of total number of deaths 
worldwide in 1990, but rose to 18th in 2010. Over 2 million people 
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worldwide currently receive treatment with dialysis or kidney transplant (Jha 
V et al., 2013).  
In India, it is estimated that prevalence of CKD is around 15 -20%. 
Prevalence of CKD stages 1,2,3,4 and 5 was 7%, 4.3%, 4.3%, 0.8% and 0.8% 
respectively (Singh A K et al., 2013). 
Chronic kidney disease is a multifaceted problem having both physical and 
psychological disturbances for the patient. CKD patients are dependent on 
procedures and a group of qualified medical professionals for the rest of his/her 
life. CKD, as a medical condition has such a degree of dependence for the 
maintenance treatment. (Vikram Ramasubramanian et al., 2015) There is also a 
considerable restraint on the selection of foods and fluids. Patients with renal 
failure often suffer from many other medical conditions and are on many different 
medications. All these factors play an important role in the emergence of various 
psychiatric morbidities in CKD patients (A De Sousa et al., 2008) 
 In previous studies, the mental disorders frequently observed in CKD 
patients are affective disorders, particularly depression, organic brain diseases 
(delirium and dementia), substance use disorders, anxiety etc. Depression is an 
independent factor for non-adherence in patients on maintenance dialysis and 
suicide is highly linked with depressed state. In previous studies, prevalence of 
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psychiatric illness has been found to be about 32% - 40% in CKD patients 
(Soykan A et al., 2004). Among psychiatric illness depression ranges from 6.5% 
to 63%, anxiety disorder 30%, somatoform disorder 32.5% (Mathew A et al.,). 
Prevalence of anxiety disorders in post renal transplantation ranges between 10% 
to 70% (Fukunishi et al., 2001) 
 
Need of the study 
CKD patients are undergoing tremendous physical, psychological, 
emotional and financial stress of high order. This may lead to negative outlook in 
these patients, because of dependency and disability. Psychiatric comorbidity in 
CKD is an important factor in determining the treatment outcome as it is 
associated with poor adherence. So it becomes important to evaluate the 
prevalence and severity of psychiatric disorders in people with CKD. Proper 
identification and treatment of psychiatric comorbidity will help improve 
treatment adherence, quality of life and illness outcome. 
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AIM AND OBJECTIVES 
•  To estimate the prevalence of psychiatric morbidity in patients with 
chronic kidney disease 
• To study the nature and severity of psychiatric manifestations in patients 
with CKD, on conservative treatment, on hemodialysis, and on renal 
transplantation. 
•  To study the role of support systems, functional level, treatment adherence 
in relation to psychiatric illness.  
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REVIEW OF LITERATURE 
Chronic kidney disease 
Worldwide, an estimated 200 million people have chronic kidney disease. 
On global level, the burden of CKD continues to increase. 10% of the population 
worldwide is affected by CKD, and millions die each year because they do not 
have access to affordable treatment.  Moreover, kidney diseases are projected to 
grow further due to many factors, including the aging general population and the 
growing prevalence of diabetes.  In people aged 65 through 74 worldwide, it is 
estimated that one in five men, and one in four women, have CKD. Importantly, 
CKD also has a strong impact on morbidity and non fatal outcomes. Among over 
300 causes accounted for in global burden of diseases (GBD) Study, CKD is the 
15th and 20th leading cause of years lived with disability and disability adjusted 
life years ( Abubecker et al., 2015). 
It is estimated that number of cases of CKD will increase 
disproportionately in developing countries, such as India, where the number of 
elderly people are increasing. (Jha V et al., 2013) The health care costs and 
economic burden of CKD are huge and not sustainable in developing countries. In 
India, it is estimated that prevalence of CKD is around 15 -20%. Prevalence of 
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CKD stages 1,2,3,4 and 5 was 7%, 4.3%, 4.3%, 0.8% and 0.8% respectively ( 
Singh A K et al., 2013). 
Chronic Kidney Disease (CKD) refers to kidney damage or reduced kidney 
function which has persisted for a minimum period of 3 months (KDOQI, 2002). 
 
Definition criteria  
1) Kidney damage for > 3 months, as defined by structural or functional 
abnormalities of the kidney, with or without decreased GFR, manifest by 
either: 
 Pathological abnormalities; or 
 Markers of kidney damage, including abnormalities in the 
composition of the blood or urine, or abnormalities in imaging tests 
2) GFR < 60mL/min/1.73m2 for > 3 months, with or without kidney 
damage. 
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Kidney damage can be identified by renal biopsy, imaging the kidney 
(looking for structural abnormalities), or more typically via the detection of 
markers of kidney damage in the blood, such as the concentrations of urea and 
creatinine, and in the urine, such as the presence of blood and protein. Proteinuria 
is the presence of significant amounts of proteins such as albumin in the urine 
(albuminuria), and is regarded as a prominent marker of kidney damage .(Keane 
et al., 1999)  
The best overall measure of kidney function is glomerular filtration rate 
(GFR)(Smith et al., 1951). GFR is defined as the volume of fluid filtered from the 
glomerular capillaries into the Bowman’s capsule per unit of time 
(mL/min/1.73m2 ). GFR is dependent upon several factors including age, sex and 
body size. A GFR of 120-130 mL/min/1.73m2 is considered normal in healthy 
adults, though this declines with age (Rowe et al., 1976; Smith et al., 1951).      
The gold-standard measure of GFR is Inulin clearance which involves an 
intravenous infusion and precisely timed urine collections. Inulin is a small 
molecule that is easily filtered through the glomeruli with no re-absorption in the 
renal tubules. However, Inulin clearance is rarely used in clinical practice because 
it is time consuming and costly.   
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Creatinine clearance is another method of estimating GFR, which is more 
applicable to clinical practice. This requires a 24 hour urine collection and an 
estimate of creatinine concentration in the serum.  Creatinine is a small molecule 
resulting from the metabolic break down of creatine phosphate found in muscle. 
Creatinine is a middle sized molecule freely filtered by the glomerulus, with little 
re-absorption in the renal tubules. Elevated levels of serum creatinine (>120 
µmol/l) suggest renal impairment. Serum creatinine affected by factors other than 
GFR, such as muscle bulk and protein intake, thus there is variation of serum 
creatinine both in patients with normal and impaired kidney function. 
Furthermore serum creatinine concentration does not rise out of the normal range 
until around 50% of GFR is lost. Hence serum creatinine alone is insufficient to 
determine the severity of kidney function. In addition, creatinine clearance 
estimations generally overestimate GFR due to tubular secretion of creatinine. 
Variation of laboratory techniques for creatinine estimation, and inaccurate 24 
hour urine collections are additional problems with this methodology. As a result 
of these issues, estimates of GFR are commonly used in clinical practice. These 
are derived from predictive equations. The two most common equations are; the 
Cockcroft-Gault equation (Cockcroft & Gault, 1976) and the Modification of Diet 
in Renal Disease (MDRD) study equation (Levey et al., 1999), which are defined 
below:  
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Cockcroft-Gault equation: Creatinine Clearance (mL/min) = ([140 – Age X 
Weight] / [72 X Serum Creatinine]) X (0.85 if female)   
MDRD equation: eGFR (ml/min/1.73m2 ) = 186 X [Serum Creatinine] -1.154 X 
[Age] -0.203 X [0.742 if female] X [1.21 if black].  
where  eGFR is estimated GFR, age is measured in years, weight in kg, serum 
creatinine in mg/dL.   
Renal failure can follow either an acute or chronic course. Acute Kidney 
Injury (AKI) is the loss of renal function in a setting in which the loss is 
potentially reversible. The onset of AKI is usually sudden with a time course of 
hours or days. CKD is the progressive deterioration of renal function resulting in 
irreversible kidney damage.  
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Stages of CKD  
Stage  Description  GFR (mL/min/1.73 m2 ) 
1 Kidney damage with normal or increased 
GFR 
≥ 90 
2 Kidney damage with mild reduction in GFR 89 – 60 
3 Moderate reduction in GFR 59 – 30 
4 Severe reduction in GFR 29 – 15 
5 End stage renal disease < 15 
 
Etiology  
Causes of CKD include 
• Diabetes is the most common cause of CKD (USRDS, 2003). Indeed, the 
rise in CKD prevalence rates over the past 10 years is partially attributable 
to the growing incidence of diabetes (USRDS, 2003). 
• Hypertension 
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• Vascular diseases (eg- renal artery stenosis, vasculities, atheroemboli, renal 
artery thrombosis) 
• Glomerular disease(primary or secondary) 
• Tubulointerstitial disease 
• Cystic kidney diseases 
• Obstructive nephropathy 
• Renal stone diseases 
• Congenital defects of kidney or bladder 
• Unrecovered acute kidney injury 
The consequences of CKD 
Early stages of renal impairment may be asymptomatic. Various “uraemic” 
symptoms can result from severe renal failure, though this is difficult to define in 
purely biochemical terms. Data from the Third National Health and Nutrition 
Examination Survey (NHANES III) demonstrated a decline in Hb with falling 
eGFR.  Dietary limitations are required to maintain adequate potassium levels, 
often involving specialist advice from renal dieticians. Similarly, phosphate 
control is regulated by dietary control and the ingestion of phosphate binder 
medications.  
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Indications for renal replacement therapy in CKD 
• Severe metabolic acidosis 
• Encephalopathy 
• Hyperkalemia 
• Pericarditis 
• Intractable volume overload 
• Intractable gastrointestinal symptoms 
•
 In asymptomatic patients, a GFR of less than 10 ml/min/m2  
Renal replacement therapy in CKD 
Hemodialysis (HD) 
The blood and the dialysis fluid are pumped through the dialyzer in a 
countercurrent fashion to maximize concentration gradients. HD works by the 
principles of convection and diffusion. Waste products are mainly removed by 
diffusion down the concentration gradient between the blood and the dialysis 
fluid. The composition of the dialysis fluid is devised to optimize the removal of 
toxins and excess minerals and electrolytes, such as potassium and magnesium, 
prevent excess removal of sodium, and to allow acidosis to be corrected by 
infusion of bicarbonate. Fluid is sucked from the blood into the dialysis fluid by 
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convection, brought about by application of a negative pressure to the dialysis 
fluid side of the membrane. Convection also facilitates the removal of middle 
molecules. Haemodialysis can take place in-centre, in minimal care units or in the 
home. In centre based therapy, nurses or health care assistants undertake most of 
the work associated with the treatment. In-centre treatment is by far the most 
common current means of dialysis delivery.  
Peritoneal Dialysis (PD) 
Peritoneal dialysis  removes metabolic end products and fluid from the body via a 
naturally occurring semi-permeable membrane. This refers to the peritoneal 
membrane which lines the peritoneal cavity and surrounds the intestine. PD 
requires the insertion of a peritoneal catheter into the patient’s abdomen. Dialysis 
fluid is then introduced into the peritoneal cavity. The same principles of 
diffusion and convection as described above also operate in peritoneal dialysis, 
except that convection now occurs down an osmotic gradient created by high 
concentrations of glucose in the dialysis fluid. Continuous ambulatory peritoneal 
dialysis (CAPD) is typically conducted throughout the day and involves four 
dialysis exchanges. Automated Peritoneal Dialysis involves the patient dialyzing 
at night, with a machine managing the exchanges over an 8-10 hour period. The 
self-care aspect associated with PD tends to mean that this modality is generally 
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suited to younger patients with less comorbidity, though older independent 
patients may also do well on this modality (Brown et al., 1999;  Brown et al. , 
2010). Of the potential complications associated with PD peritoneal infection is a 
prominent concern. It usually responds to antibiotics but in rare cases may be 
fatal. 
Renal transplantation 
Transplantation Renal transplantation is the preferred treatment for end stage 
renal disease (ESRD), though only minorities of patients are suitable. This 
reflects the increasing age and co-morbid load of the ESRD population. A 
successful transplant often reverses some of the complications induced by kidney 
failure, including anemia and infertility. Furthermore, the need for tight dietary 
and fluid restriction is no longer required. Transplantation involves the donation 
of a kidney either from a living related donor or a “brainstem dead” donor 
(cadaveric). The benefits of renal transplantation are well established, improving 
both survival and quality of life. However the demand for donor kidneys 
outweighs the supply, which prolongs patient’s reliance upon dialysis therapies. 
Successful transplantation generally relies upon matching blood group antigens, 
though exceptions are increasingly common. HLA matching may improve 
outcomes but mismatching is generally not a barrier. Following a transplant, 
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immunosuppressive medication is required. Advances in this regard have led to 
transplanted kidney surviving longer, with around 50% lasting 10 years or more.  
CKD and psychiatric illness 
The psychiatric disorders associated with kidney disease take many forms, 
depending on the natural history of disease. As in every chronic condition, patient 
with chronic kidney disease may suffer from limited functional capacity, impaired 
productivity, and reduced quality of life. Psychiatric disorders are highly 
prevalent in patients with CKD. Kimmel et al reported that chronic kidney disease 
patients had to be hospitalized for psychiatric disorders 1.5 to three times more 
than individuals with other chronic diseases. 
The psychiatric manifestations of renal failure were described by Addison 
in 1868 in his classic monograph on renal disease.( J Donovan et al,.1971) He 
wrote that these patients manifested ‘a dullness of the intellect, sluggishness of 
manner, drowsiness going on to quiet stupor and ending in coma’. 
Schreiner(1959) and Tyler(1965) agree that the commonest initial complaints of 
the uremic patient are fatigue, drowsiness and inability to concentrate for long 
periods. Schreiner comments that delirious psychosis may arise even in the early 
stages of alteration of consciousness but increase in frequency occurs along with 
deterioration of the general mental state.  
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     The relationship between depression and physical illness is highly 
intimate. It is evident that depression and other psychiatric symptoms are 
implicated in both the etiology and consequence of physical illness. Co-morbid 
depression has profound effects upon morbidity, mortality, self-care behaviour 
and health care costs in patients with chronic physical disease (Stein et al., 2006). 
At any given time it is thought that 2 to 4% of the general population suffers from 
depression, rising to between 5 and 10% in primary care (Kessler et al., 2003). 
Among patients with CKD the reported point prevalence of depression or 
significant depressive symptoms is estimated to be between 20-30% (Cukor et al.,  
2008; Drayer et al. , 2006; Kimmel et al. , 2005). However, the use of different 
depression assessment tools has lead to wide variation in estimated prevalence 
rates (Craven et al., 1987; Craven et al., 1988; Smith et al., 1985).  Furthermore, 
there are discrepancies in prevalence estimates between patients receiving various 
treatment modalities, although methodological factors may contribute to this 
mixed evidence. Despite this depression is thought to be the most common 
psychopathology encountered in chronic kidney disease patients, the under 
recognition of which in day-to-day clinical practice is of considerable concern 
(Wang et al., 2004). This concern is exacerbated by the growing body of 
empirical evidence identifying the adverse consequences of depression on clinical 
outcome in CKD patients. 
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 Prevalence of depression and depressive symptoms in CKD 
 The montage of research in the area suggests that depression accounts for 
around 50% of the psychopathology encountered in chronic physical illness. As 
in patients with CKD the estimated prevalence of depression among patients with 
other physical illnesses is varied, and depends on the definition of depression 
employed and the type of depression measurement administered (Meakin et al., 
1992). As a consequence, estimates of the prevalence of depression range 
between 15 and 61%, among the medically ill (Martucci et al., 1999). As stated 
previously, screening approaches generally inflate estimations compared to 
diagnostic assessments. For example, Smith et al (1985) compared three 
depression assessments among patient with ESRD, reporting varying prevalence 
rates across the assessments. When using the BDI (cut-off >11), 47% had 
significant symptomatology, compared to 17% when using the Multiple Affect 
Adjective Checklist and 5% after a professional diagnostic evaluation. In a recent 
study of ESRD patients treated with haemodialysis and peritoneal dialysis 
(n=128), 45.3% had a BDI≥14, while no differences between treatment modalities 
were apparent (Simic Ogrizovic et al., 2009). Investigations employing diagnostic 
criteria among ESRD patients generally reveal lower estimates of depressive 
disorder, yet there is still variation across studies. 
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 A large epidemiology study reports that ESRD was associated with nearly 
a fourfold increase in depression prevalence as compared to healthy individuals 
(Egede et al., 2007). Moreover as is common in patients with ESRD, only 12% of 
the patients assessed were receiving treatment for depression or anxiety disorders 
(Cukor et al., 2007). Grant et al (2008) revealed a 12.3% prevalence rate after 
applying ICD- 10 classification for depression to 57 HD patients. Others report a 
17.3-19% prevalence of major depressive disorder (MDD) in HD patients 
(Hedayati et al. , 2006; Watnick et al., 2005).  Depression was found to be 
constant across CKD stages, with 21% of the sample meeting the criteria for 
MDD. Despite this limitation and the paucity of research in CKD, depression may 
be a prevalent psychopathology in early stages of kidney disease.  
The course of Depression in CKD  
A recent longitudinal study of HD patients, reports a 29% prevalence rate 
for depressive disorder using the Structured Clinical Interview for DSM (SCID) at 
baseline assessment (Cukor et al., 2008). Interestingly, 43% of patients diagnosed 
with depressive disorder at baseline, still satisfied the criteria 16 months later. A 
persistent depressive course was associated with reduced perceived health status 
and quality of life and a depressive history (Cukor et al., 2008). These results may 
imply that depression is relatively stable over time in ESRD patients. Although 
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this study had a relatively small sample size, it provides insight into the course of 
depression over time among CKD patients.  
The impact of depression in CKD  
The impact of depression upon health related outcome is tangible. In a 
recent study of HD patients, depression symptoms were associated with 
significantly more hospital admissions and emergency department visits 
(Tavallaiiet al., 2009). In the general population depression is associated with 
increased mortality risk (Wulsinet al., 1999), although methodological issues 
confound certain studies. A recent study investigated the impact of depression 
and anxiety symptoms using the Hospital Anxiety and Depression Scale  upon 
mortality in a large population survey (Mykletun et al., 2009). In a comprehensive 
analysis, the authors were able to demonstrate a significant effect of depressive 
symptoms upon survival after controlling for several factors including somatic 
conditions, physical activity and smoking status (OR=1.37, 95% CI 1.19 to 1.58). 
29 Interestingly the adjustment of somatic conditions led to an attenuation of the 
depression mortality association. Physical illness is therefore an important 
confound in this context, and suggests further the intimate relationship between 
depression and physical illness. 
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 Cardiovascular disease (CVD) is a prominent co-morbidity among the 
dialysis population and one of the largest contributors of mortality. There is also a 
comprehensive literature linking depression with CVD (Steptoeet al., 2007). Pro-
inflammatory cytokines appear to be heightened in CKD patients and predict 
mortality (Kimmelet al., 1998). There is evidence that depression is associated 
with these cytokines including IL- 6, IL-1β and TNF-α and CRP in both the 
general and ESRD populations (Appelset al., 2000; Kop et al. , 2002; Simic 
Ogrizovic et al. , 2009; Suarez et al., 2003). In a recent study, CKD patients with 
a BDI≥14 had significantly higher IL-6 and hsCRP as compared to those with a 
BDI less than 14. Recently the association between a formal diagnosis of clinical 
depression and mortality has been established (Hedayati et al., 2008). Ninety 
eight HD patients were assessed using the SCID, which identified 26 as suffering 
from depressive disorder. Differences between the depressed (as diagnosed via 
the SCID) and non-depressed revealed a greater prevalence of co-morbidity in the 
depressed. In multivariate analysis after controlling for age, ethnicity, gender, 
time of dialysis and co-morbidity, a diagnosis of depression was significantly 
associated with mortality. Interestingly, self-report measures were not significant 
predictors of mortality in sub-analysis. In summary there is considerable evidence 
regarding the association between depression and mortality in CKD patients. 
While further research is required to better understand this relationship, it is also 
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important to establish the utility of treating depression upon patient outcome of 
which the current evidence is mixed (Detweiler-Bedellet al., 2008).  
Depression and Non-Adherence in CKD 
Depression may be associated with increased health care costs and 
mortality due to decreased treatment adherence in these patients (DiMatteo et 
al.,2000). A meta-analysis of depression and medical treatment non-adherence 
suggests that depression increases the odds of non-adherence 3 fold (odds ratio 
3.3, 95%CI 1.96 to 4.89, DiMatteo et al., 2000). Interestingly analysis of six 
ESRD studies were reported in this metaanalysis, revealing a standardized odds 
ratio of 3.44 (95% CI 1.26-8.1, p=0.008) for nonadherence in depressed patients. 
Critically however, this analysis did not weight the effect size for methodological 
strengths for each study reported. A recent review of the literature evaluated the 
association between depression and non-adherence more cautiously (Raynor et 
al., 2006). Indeed, while 37% of the studies reviewed (n=41), report a significant 
negative association, a similar number reported that depression was related to 
some aspects of non-adherent behaviour but not all. These findings highlight the 
complexity of adherence and show that predictors may only partially explain one 
aspect of what are often demanding and multifaceted treatment regimes. 
Furthermore measuring adherence in the CKD is a particular issue due to several 
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clinical confounders (Leggat et al., 1998). Kimmel et al (1998) suggest 
investigating behavioural non-adherence relating to the 32 dialysis treatment (i.e. 
shortening dialysis time and skipping dialysis sessions). They demonstrated that 
depression symptoms were associated with behavioural nonadherence, and that 
non-adherence predicted mortality. However in this particular analysis they failed 
to find any association between depression symptoms and mortality. Recently the 
influence of depressive symptoms upon medication adherence in both CKD and 
kidney transplantation patients has been investigated (Cukor et al., 2009). The 
results showed that depressive symptomatology added significantly to the 
explained variation of medication adherence in both CKD and transplant patients. 
Given this, it may be hypothesised that treating depression in CKD patients would 
improve patient adherence.  
Anxiety in CKD 
Anxiety is also commonly seen in CKD patients. Cukor et al (2008) reported that 
45.7% of a group of dialysis patients met criteria for an anxiety disorder. The 
most prevalent disorders were specific phobias (26.6%) and panic disorder (21%). 
Bossola et al.(2010) indicated that 47.5% of 80 HD patients had symptoms of 
anxiety. In addition, the anxiety scores correlated significantly with age and 
comorbidities, and anxiety were commonly noted in patients with poor appetite 
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(Bossola et al., 2010). In a study by Chen et al., (2010), 21% of dialysis patients 
had symptoms of anxiety. In addition, 15.5% of these patients had comorbid 
depression and anxiety, and 44% of depressed patients had comorbid anxiety.   
Suicide in CKD 
Suicide may be the most serious result of mental illness among CKD patients. 
Kurella et al(2005) reported the death rate from suicide was 0.24% in HD 
patients.  Chen et al., (2010) demonstrated that among 200 patients with HD, 
21.5% had suicidal ideation; 3.5% had planned a suicide attempt in prior months; 
and 3.5% had attempted suicide during their lifetime. Suicide was associated with 
several demographic characteristics among HD patients. Independent predictors 
of suicide included old age, male gender, lower educational status, alcohol or 
drug dependence, and recent hospitalization for mental illness (Keskin et al., 
2011; Kurela et al., 2005). Suicide risk was also significantly predicted by 
depression and anxiety.  Because suicide might be preventable via early detection 
of warning signs, it is crucial to identify the psychological impact and possible 
risk of suicide among dialysis patients. 
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Cognitive alterations in CKD  
Cognitive deficits in patients with chronic kidney disease are common but poorly 
recognized. The identification of deficits may have a positive impact on patient 
outcome, especially when they are secondary to depression or delirium, 
potentially treatable conditions that must be considered in the differential 
diagnosis of cognitive impairment( Kurella Tamura M et al.,2011). Alzheimer’s 
and vascular dementia in particular are commonly seen in patients with CKD, the 
latter due to comorbidites with hypertension, diabetes and atherosclerosis. 
Dementia has been associated with greater levels of disability, more deaths and 
hospitalizations and interruption of dialysis (Kurella Tamura M et al., 2011). 
Patients on dialysis for more than a year may suffer from a progressive 
neurological syndrome called ‘dialysis dementis’, characterized by dysarthria, 
dysphagia, and global dementia with preservation of the level of consciousness. 
Individuals with dialysis dementia may die within 6 -12 months if not treated 
properly. The most widely accepted pathophysiology of dialysis dementia 
revolves around toxicity of the aluminum salts found in dialysis fluids. The 
introduction of preventive measures (discontinuation of the use of aluminum salts 
in dialysis fluids and phosphate binders containing aluminum) led to a significant 
reduction in the number of cases (Wyszynski A A et al., 2008). 
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Delirium 
Delirium is an acute behavioural disturbance caused by brain dysfunction, 
leading to cognitive impairment usually secondary to a systemic disorder. It is 
characterized by abrupt onset, altered level of consciousness, attention deficits, 
temporal/spatial disorientation, disorganized thinking, and fluctuation of 
symptoms throughout the day. Many are the precipitating factors for delirium in 
renal failure. They include fever, hemodynamic instability, polypharmacy, 
hypo/hypernatremia, acid-base imbalance, hypercalcemia, hypo/hyperglycemia, 
anemia and vitamins deficiency. However, in patients with renal failure, some 
specific cause must be considered such as uremia, aluminium toxicity, subdural 
hematoma (associated with platelet dysfunction and anticoagulants), and dialysis 
disequilibrium syndrome ( Polycarpou et al., 2007). 
Dialysis disequilibrium syndrome is caused by a sudden correction in 
azotemia and a consequent change in pH and oscmotic pressure, which produce a 
pressure gradient between the central nervous system and plasma, leading to 
cerebral edema. Dialysis disequilibrium syndrome may set in 3 - 4 hrs after the 
start of dialysis and may last for 8 – 48 hours after the end of dialysis. It is a 
transient condition characterized by headaches, nausea, cramps, delirium, 
epileptic seizures and coma. 
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Early detection of delirium is of paramount importance and treatment must 
be individualized for each patient. Prevention is the first step when it comes to 
dealing with delirium. This can be done by identifying and treating predisposing 
factors and with early patient immobilization. There is no evidence to support the 
use of drugs in the prevention of delirium. 
Uremic encephalopathy 
Uremia is described as a clinical syndrome associated with renal failure 
and accumulation of nitrogen compounds. However, no specific substance has 
been implicated to date. Factors such as hormonal disorders, oxidative stress, 
accumulation of metabolites (such as guanidine compounds, kynurenine pathway 
metabolites), imbalance between excitatory and inhibitory neurotransmitters, and 
disorders of intermediary metabolism have been identified as possible 
contributing factors. Uremic encephalopathy is more severe and progresses more 
rapidly in patients with acute deterioration of renal function. 
In addition to the symptoms present in delirium, in uremic encephalopathy 
symptoms may progress along a continuum, from mildly altered levels of 
consciousness to deep coma. Headache, visual disturbances, tremor, multifocal 
myoclonus, and epileptic seizures are frequently present. Clinical signs also 
fluctuate over hours or days. Patients may experience progressive cognitive 
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impairment. However, levels of azotemia (nitrogen compounds) have been poorly 
correlated with neurological disorders. Most symptoms resolve with dialysis or 
transplantation (Brouns R et al., 2004) 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
MATERIALS AND METHODS 
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METHODOLOGY 
• Study design 
• Cross sectional study 
• Study place 
• Department of Nephrology, Kilpauk Medical College 
• Duration of study 
• 6 months 
Sample size calculation 
N=4pq/d*d  
N- total sample size, p – prevalence, q – 100-prevalence, d-precision 
P = 40% (prevalence of psychiatric illness in CKD) 
 absolute precision = 10%   
Calculation: 4 x  (0.40 x 0.60) / (0.1 x 0.1) = 96 
Assuming 10 % non-response = 96 + 10 = 106.  
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Inclusion criteria 
Patients diagnosed to have Chronic Kidney Disease by Consultant 
Nephrologist and on various treatment modalities (conservative treatment, 
hemodialysis, renal transplantation) in department of Nephrology, Kilpauk 
Medical College Hospital. 
Age between 18 – 60 years 
Given consent for the study 
 
Exclusion criteria 
 Patients diagnosed to have mental illness prior to the onset of CKD 
 Refused to give consent to the study 
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MATERIALS AND METHODS 
 A total of 110 consecutive patients getting various treatments (conservative 
treatment, hemodialysis, renal transplantation) at nephrology department in Govt. 
Kilpauk Medical College, fulfilling the inclusion and exclusion criteria were 
selected for this study. Informed consent was obtained from those willing to 
participate. A semi structured socio demographic proforma (Name, age, hospital 
no., gender, education, occupation, family income per month, marital status, type 
of family) and Kuppuswamy socioeconomic status scale  were applied to the 
participants. Information regarding disease related factors like age at renal disease 
diagnosis, underlying cause of renal failure, renal failure stage, mode of treatment 
receiving, duration of treatment, co-morbid medical illness and family history of 
psychiatric illness also collected. Symptom Check List 90 was used to screen for 
psychiatric disorders, ICD 10 guidelines  used for diagnosis of psychiatric 
disorders, Hamilton Depression rating scale  and Hamilton Anxiety rating scale   
used for assessing the severity of depressive and anxiety disorders respectively. 
Severity of alcohol dependence questionnaire score was used to assess the 
severity of alcohol dependence. Montreal cognitive assessment was used for 
assessing cognitive functions. Multidimensional scale of perceived social support 
system,  Karnofsky performance scale were also applied for assessing the support 
system, functional ability respectively.  
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Ethical approval 
 Ethical approval for the study was obtained from the Ethics committee, 
Government Kilpauk Medical College, Chennai. 
Tools  used 
1) A semi structured socio demographic proforma (Name, age, hospital no., 
gender, education, occupation, family income per month, marital status, 
type of family). 
2) Kuppuswamy socioeconomic status scale 
3) Symptom checklist – 90 – to screen the patients 
4) ICD – 10 clinical and diagnostic guidelines – to confirm the diagnosis 
5) HAM-D – to assess depression severity 
6) HAM – A – to assess anxiety severity 
7) Severity of Alcohol Dependence Questionnaire (SADQ) – to assess   
Alcohol dependence severity 
8) Montreal Cognitive Assessment (MOCA) – to assess cognitive 
functions. 
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9) Multidimensional Scale of Perceived Social Support – to assess support 
system 
10) Karnofsky Performance Status Scale (KPS) – to assess functional 
ability of the patients. 
11) Morisky’s medication adherence Scale (MMAS) – to assess medication 
adherence 
Kuppuswamy socioeconomic status scale 
 Kuppuswamy socioeconomic status scale is a widely used scale to assess 
the socioeconomic class of study participants. It was published in 1981 originally 
but modifications have been published regularly to account for the changing price 
index. It has three categories to be scored-educational level of the head of the 
family, occupation of the head of the family and income per month. Education is 
scored from 1 to 7, occupation from 1 to 10 and monthly family income from 1 to 
12. The total is added up. There are five socioeconomic classes that can be 
derived from the scale-upper, upper middle, middle/lower middle, lower/upper 
lower and lower. The scale needs modification from time to time because of the 
changing price index that affects the validity of the income per month subset in 
the scale (Kumar BR et al., 2012, Sharma R et al., 2014, Patro BK et al., 2012). 
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Symptom Checklist -90 Revised 
The Symptom checklist-90-R is a self-report psychometric instrument 
(questionnaire) published by the clinical assessment division of the Pearson 
assessment and information group. It is used to screen for and evaluate a wide 
range of psychological problems and symptoms of psychopathology. It consists of 
90 items, yielding 9 scores along primary symptoms and 3 scores among global 
distress indices. The primary symptoms that are assessed are somatization, 
obsessive-compulsive, depression, anxiety, interpersonal sensitivity, phobic 
anxiety, paranoid ideation, .hostility and psychotism. The three global distress 
indices are global wellness index, hardiness and symptom free. The internal 
consistency coefficient rating ranged from 0.80 for depression and 0.77 for 
psychotis(Pearson, 2016) It is one of the most widely used measures of 
psychological distress in research and clinical practice.    
Hamilton depression rating scale 
 The Hamilton depression rating scale was developed in the 1950s. It is a 
clinician administered scale and is one of the widely used scales in psychiatry.  
The scale was originally designed with 21 items. Later, 4 items (diurnal variation, 
de-realization, paranoid symptoms and obsessional symptoms) were dropped. 
Diurnal variation was considered as not being a measure of depression or its 
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intensity. Others were considered as being infrequent. There are now 17 items in 
the scale, though the original 21 items version is also sometimes used. In this 
study, we used the 17 item version. The following are the items in the scale: 
depressed mood, feeling of guilt, suicide, insomnia early, insomnia middle, 
insomnia late, work and activities, retardation, agitation, anxiety (psychic), 
anxiety(somatic), somatic symptoms (gastrointestinal), somatic symptom 
(general), genital symptoms, hypochondriasis, loss of weight and insight. Each 
item is scored on a three to five point scale (0-2 to 0-4). Individual scores are later 
summed up to give a total score. The scale has been shown to be sensitive over a 
wide range of depression severity in studies. The inter-rater reliability for the 
scale has also been found to be good (0.82) (Cicchetti DV et al., 1983). Internal 
consistency of the scale was found to be 0.83. Validity of the scale range from 
0.65 to 0.90 with global measures of severity of depression in studies. Validity 
also highly correlated with behavioral features, and somatic features account for 
about half of the total possible score in the scale. The maximum possible total 
score on the scale is 52. The scale is considered as a standard instrument. 
(Hamilton M et al.,1960, Williams JP et al.,1988, Carroll BJ et al.,1973, Baer L et 
al., 2010). 
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 Hamilton anxiety rating scale 
  The Hamilton anxiety rating scale was designed to quantify anxiety in 
patients already diagnosed with anxiety disorders. The scale was not intended to 
be a diagnostic tool. The scale was also not meant for using disorders other than 
neurotic anxiety states. The scale contains 14 items and is clinician administered. 
It takes about 15 to 30 minutes to administer the scale. The individual items are: 
anxious mood, tension, fears, insomnia, intellectual, depressed mood, somatic 
(muscular), somatic (sensory), cardiovascular systems, respiratory systems, 
gastrointestinal systems, genitourinary systems, autonomic systems and behavior 
at interview. Each item is scored on a five point scale 0 to 4. The scores are all 
added up to yield the total score. In addition to the total score, two subscales have 
been suggested-cyclic subscale and somatic subscale. A scale has been evaluated 
for reliability and has been found to have an inter-rater correlation of 0.89. 
Internal consistency ranges from 0.77 to 0.92. (Hamilton MA et al., 1959, Maier 
W et al.,1988, Baer L et al.,2010). 
Severity of Alcohol Dependence Questionnaire (SADQ) 
  The Severity of Alcohol Dependence Questionnaire is a 20 item screening 
tool used to assess the presence and level of alcohol dependence.  
There are 5 subscales with 4 items in each: 
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1) Physical withdrawal symptoms   
2) Affective withdrawal symptoms 
3) Craving and relief drinking 
4) Typical daily consumption 
5) Rapidity of reinstatement. 
Each item is scored on a 4-point scale, ranging from “almost never” to 
“nearly always”, resulting in a score of 0 to 3. The total maximum score possible 
is sixty and the minimum is 0. A score of 31 or higher indicates “severe alcohol 
dependence”. A score of 16 to 30 indicates “moderate dependence”. A score of 
below sixteen indicates only a mild dependency.   
Montreal Cognitive assessment  
Montreal Cognitive assessment was created in 1996 by Ziad Nasreddine in 
Montreal, Quebec. It is a one page 30-point test administered in approximately 
ten minutes. MoCA scores range between 0 and 30. A score of 26 or above is 
considered to be normal.It assesses several cognitive domains. The short term 
memory recall task (5 points) involves two learning trials of 5 nouns and delayed 
recall after 5 minutes. Visuospatial abilities are assessed using a clock-drawing 
task (3 points) and a 3-dimensional cube copy (1 point). Executive functions are 
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assessed using an alternation task adopted from the trial making B task (1 point), 
a phonemic fluency task (1 point) and a two – item verbal abstraction task (2 
points). Attention, concentration and working memory are evaluated using a 
sustained attention task (target detection using tapping; 1 point), serial subtraction 
task (3 points), and digits forward and backward (1 point each) language is 
assessed using a 3 –item confrontation naming task with low-familiarity animals 
(lion, camel, rhinoceros; 3 points), repetition of two syntactically complex 
sentences (2 points). Finally, orientation to time and place is evaluated. 
(Nasreddine Z et al.,2005) 
Multidimensional Scale of Perceived Social Support 
A number of studies have demonstrated that social support functions as a 
buffer for psychological distress.  In an attempt to measure social support, Zimet 
et al. developed   the Multidimensional Scale of Perceived Social Support, which 
has been widely used in both clinical and non clinical samples. ( zimet et al., 
1988) 
The MSPSS is intended to measure the extent to which an individual 
perceives social support from three sources: Family (Items 3, 4, 8, and 11), 
Friends (Items 6, 7, 9, and 12) and Significant others (Items 1, 2, 5, and 10). The 
MSPSS is a brief, easy to administer self report questionnaire which contains 12 
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items rated on a seven point Likert-type scale with scores ranging from ‘very 
strongly disagree’ to very strongly agree. The MSPSS has proven to be 
psychometrically sound in diverse samples and to have good internal reliability 
and test-retest reliability, and robust factorial validity. 
Karnofsky Performance Status Scale (KPS) 
The Karnofsky Performance Status Scale index allows patients to be 
classified as to their functional impairment. This can be used to compare 
effectiveness of different therapies and to assess the prognosis in individual 
patients. The lower the Karnofsky score, the worse the survival for most serious 
illness. The Karnofsky Performance Score ranking runs from 100 to 0, where 100 
is “perfect” health and 0 is death. This scoring system is named after Dr. David 
A. Karnofsky who described the scale in 1948. (Karnofsky et al)  
100- Normal; no complaints; no evidence of disease. 
90- Able to carryon normal activity; minor motor signs or symptoms of disease 
80- Normal activity with effort; some signs or symptoms of disease. 
70- Cares for self; unable to carry on normal activity or to do active work. 
60- Requires occasional assistance, but is able to care for most of his personal 
needs. 
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50- Requires considerable assistance and frequent medical care. 
40- Disabled; require special care and assistance. 
30- Severely disabled; hospital admission is indicated although death not 
imminent’ 
20- Very sick; hospital admission necessary; active supportive treatment 
necessary. 
10- Moribund; fatal processes progressing rapidly. 
0- Dead. 
Morisky’s medication adherence Scale (MMAS) 
The MMAS is a generic self-reported, medication- taking behavior in 
which the specific health issue is inserted for the health concern. The MMAS 
consists of four items with a scoring scheme of “yes”=0 and “No”=1. The items 
are summed to give a range of scores from 0 to 4. 
 Statistical analysis 
Statistical analysis was done using SPSS, to assess the prevalence of 
psychiatric illness in CKD patients, and to assess the type and severity of 
psychiatric illness and their proportion in relation to treatments ( conservative, 
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hemodialysis, post renal transplantation), and to study the association between 
psychiatric illness and the factors like support systems, patients functional level, 
treatment adherence. P value was taken to be significant if it was <0.05. 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
RESULTS 
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RESULTS 
 A total of 118 patients were approached for the study. Of these, 5 patients 
did not given consent to participate in the study and 3 were dypnoeic, hence not 
included in the study. The remaining 110 patients consented to participate in the 
study. Informed consent was obtained from all these participants. 
Of these 110 patients, 36.4% (n=40) were in conservative treatment, 31.8% 
(n= 35) were in hemodialysis, 31.8% (n=35) were post renal transplant patients. 
Among the patients in conservative treatment 50% (n=20) were males and 50% 
(n=20) were females. About 2.5% were in the age group of 18 - 39 years, 42.5% 
in the 40 – 59 age group, 55% in the 60 or more years. About 15% had nil formal 
education, 47.5% had studied upto primary level and 37.5% had studied upto 
secondary level. Majority were from upper lower socio economic status (42.5%), 
25% from lower, 27.5% from lower middle and 5% from upper middle socio 
economic status. Majority were Hindu(80%) and 2.5% Muslims, 17.5% 
Christians.90% were from urban background, majority of them were 
unemployed(85%) and 10% doing unskilled work, 2.5% doing semiskilled, 2.5%  
doing skilled works. Majority were married (77.5%), from nuclear family 
(77.5%) 
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Among the patients in hemodialysis,  57.1% (n=20) were males and 42.9% 
(n=15) were females. 51.4% were in the age group of 18 - 39 years, 25.7% in 40 -
59 years age group, 22.9% in the 60 and more years. About 11.4% had nil formal 
education, 40% had studied upto primary level, 25.7% had studied upto 
secondary level and 22.9% had studied upto the graduate level. 34.3% from lower 
and upper lower socio-economic status respectively, 25.7% from lower middle 
and 5.7% from upper middle socio-economic status. Majority were Hindu(74.3%) 
and 20% Muslims, 5.7% Christians.82.9% were from urban background, majority 
of them were unemployed(74.3%) and 5.7% doing unskilled work, 5.7% doing 
semiskilled, 8.6%  doing skilled works, 5.7% were professionals. Majority were 
married (71.4%), from nuclear family (82.9%) 
In post transplanted patients 57.1% were males, 42.9% were females. 
74.3% were in the age group of 18 - 39 years, 25.7% were in 40 -59 years age 
group. 2.9% had nil formal education, 8.6% had educated upto primary level, 
57.1% had educated upto secondary level, 31.4% had educated upto the graduate 
level. 40% were in lower middle socio-economic status, 34.3%from upper lower, 
5.7% from lower, 20% from upper middle socio-economic status. No one was 
from upper socio-economic status in all 3 groups. Majority were Hindu(85.7%) 
and 8.6% Muslims, 5.7% Christians.71.4% were from urban background, 
majority of them were unemployed(42.9%) and 20% doing unskilled work, 
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17.1% doing semiskilled, 14.3%  doing skilled works, 5.7% were doing 
professional work. Majority were married (77.1%), from nuclear family (74.3%) 
(Table - 1) 
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Table-1: Socio-demographic profile of the study population 
s.
n 
Socio-demographic variable Conservative treatment(N=40) 
   n(%) 
Hemodialysis (N=35) 
n (%) 
Post renal transplantation (N=35) 
   n(%) 
1 Age (years) 18 – 39 1 (2.5) 18 (51.4) 26 (74.3) 
40 -59 17 (42.5) 9 (25.7) 9 (25.7) 
60 or more 22 (55) 8 (22.9) - 
2 Sex Male 20 (50) 20 (57.1) 20 (57.1) 
female 20 (50) 15 (42.9) 15 (42.9) 
3 Education Illiterate 6 (15) 4 (11.4) 1 (2.9) 
 Primary level 19 (47.5) 14 (40) 3 (8.6) 
Secondary level 15 (37.5) 9 (25.7) 20 (57.1) 
graduate - 8 (22.9) 11 (31.4) 
4 Socio-economic 
status 
Upper - - - 
Upper middle 2 (5) 2 (5.7) 7 (20) 
Lower middle 11 (27.5) 9 (25.7) 14 (40) 
Upper lower 17 (42.5) 12 (34.3) 12 (34.3) 
lower 10 (25) 12 (34.3) 2 (5.7) 
5 Religion Hindu 32 (80) 26 (74.3) 30 (85.7) 
Muslim 1 (2.5) 7 (20) 3 (8.6) 
Christian 7 (17.5) 2 (5.7) 2 (5.7) 
6 Locality Rural 4 (10) 6 (17.1) 10 (28.6) 
urban 36 (90) 29 (82.9) 25 (71.4) 
 7 Occupation Unemployed 34 (85) 26 (74.3) 15 (42.9) 
Unskilled work 4 (10) 2 (5.7) 7 (20) 
Semi skilled 1 (2.5) 2 (5.7) 6 (17.1) 
Skilled work 1 (2.5) 3 (8.6) 5 (14.3) 
profession - 2 (5.7) 2 (5.7) 
8 Marital status Single - 6 (17.1) 8 (22.9) 
Married 31 (77.5) 25 (71.4) 27 (77.1) 
Separated  9 (22.5) 4 (11.4) - 
9 Family type Nuclear 31 (77.5) 29 (82.9) 26 (74.3) 
Joint  9 (22.5) 6 (17.1) 9 (25.7) 
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Showing various age groups of the study population 
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 of the study population
 
5.7
20
25.7
40
34.3 34.334.3
5.7
17.1
22.9
71.4
77.1
11.4
hemodialysis post renal 
transplantation
 
 
 
upper middle
lower middle
upper lower
lower
single
married
separated
47 
 
Chronic kidney disease related factors 
Data regarding various chronic kidney disease related factors - age at renal 
disease diagnosis, cause for renal failure, renal failure stage, duration of 
treatment, co-morbid medical illnesses, and serum creatinine level were analysed. 
(Table – 2) 
In conservative treatment group, mean age of renal disease diagnosis was 
55.10 ± 9.06years. The reported underlying causes for renal failure were systemic 
hypertension (32.5%), diabetes mellitus (15%), glomerulonephritis (12.5%), 
others include over the counter tablet ingestion (10%), unknown (7.5%). About 
42.5% were in renal failure stage 3, 27.5%in stage 2, 12.5% in stage 4 and 17.5% 
in stage 5. About 57.5% were on treatment for more than 2 years, 30% were 
within 1 year and 12.5% were on treatment for1 to 2 years. About 52.5% had 
atleast one medical comorbidity. 
 
 
 
 
 
 Reported causes for renal failure disease in conservative treatment group
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In hemodialysis treatment group, mean age of study population was 42.31 
± 15 years.  Mean age of renal disease diagnosis was 39.14 ± 14.7 years; the 
cause for renal failure was systemic hypertension (37.1%), glomerulonephritis 
(20%), unknown (17.1%), other causes (14.3%), diabetes mellitus (5.7%). All 
patients were in stage 5 renal failure. About 51.4% were undergoing hemodialysis  
for less than a year, 42.9% were on treatment for 1-2 years, and 5.7% were on 
hemodialysis for more than 2 years. About 77.1% had at least one of the medical 
comorbidity. 
Reported causes for renal failure in hemodialysis group 
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In post renal transplantation patients, mean age of the study population was 
33.51 ± 9.92 years. Mean age of renal disease diagnosis was 28.23 ± 9.632 years. 
The causes for renal disease were systemic hypertension (31.4%), 
glomerulonephritis (22.9%), unknown (17.1%), others (14.3%), diabetes mellitus 
(11.4%). Prior to transplantation all were in stage 5 disease and post 
transplantation 5.7% were in stage 2 renal failure. 
About 91.4% had undergone cadaver kidney transplantation, 8.6% were 
undergone live renal transplantation. About 45.7% were in post transplantation 
treatment for more than 2 years, 28.6% were in post transplantation period of 1 -2 
years and 25.7% were within one year of post transplantation. About 14.3% had 
at least one medical co-morbidity. 
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Reported causes for renal failure in post renal transplantation group 
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Table – 2: Chronic kidney disease related factors in the study population 
s.n CKD related factors Conservative treatment 
 N = 40 
Hemodialysis 
N = 35 
Post renal transplantation  
N= 35 
1 Age (mean years with s.d) 58.83 ± 8.691 42.31 ± 15 33.51 ± 9.92 
2 Age at renal disease 
diagnosis (mean years with 
s.d) 
55.10 ± 8.691 39.14 ± 14.7 28.23 ± 9.632 
3 Cause for renal failure n (%) 
  Diabetes mellitus 
  Systemic hypertension 
  DM + SHT 
  glomerulonephritis 
  Others 
  unknown 
 
6 (15) 
13 (32.5) 
9 (22.5) 
5 (12.5) 
4 (10) 
3 (7.5) 
 
2 (5.7) 
13 (37.1) 
2 (5.7) 
7 (20) 
5 (14.3) 
6 (17.1) 
 
4 (11.4) 
11 (31.4) 
1 (2.9) 
8 (22.9) 
5 (14.3) 
6 (17.1) 
4 Renal failure stage     n (%) 
  Stage 2 
  Stage 3 
  Stage 4 
  Stage 5 
 
11 (27.5) 
17 (42.5) 
5 (12.5) 
7 (17.5) 
 
 
 
 
35 (100) 
 
2 (5.7) 
5 Duration of treatment   n (%) 
  Less than 1 year 
  1 -2 years 
  More than 2 years 
 
12 (30) 
5 (12.5) 
23 (57.5) 
 
18 (51.4) 
15 (42.9) 
2 (5.7) 
 
9 (25.7) 
10 (28.6) 
16 (45.7) 
6 Sr. creatinine level (mean 
value) 
2.74 ± 1.352 5.83 ± 2.571 1.51 ± 0.780 
7 Comorbid medical illness 
  Present 
  absent 
 
21 (52.5) 
19 (47.5) 
 
27 (77.1) 
8 (22.9) 
 
5 (14.3) 
30 (85.7) 
 
54 
 
 
Prevalence of psychiatric illnesses in the study population 
Of the 110 patients who participated in the study, 47 (42.7%) had at least 
one psychiatric illness. Among groups 21 (52.5%) patients in conservative 
treatment, 15 (42.9%) patients in hemodialysis, 11 (31.4%) post renal 
transplantation patients had psychiatric illness. (Table – 3) 
Table – 3: Prevalence of psychiatric illnesses in the study population 
s.n Psychiatric illness Conservative 
treatment 
(N = 40) 
n(%) 
Hemodialysis 
(N = 35) 
n(%) 
Post renal 
transplantation 
( N = 35) 
n(%) 
1 Presence of 
psychiatric illness 
21 (52.5) 15 (42.9) 11 (31.4) 
2 Absence of 
psychiatric illness 
 
19 (47.5) 
 
20(57.1) 
 
24 (68.6) 
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Prevalence of psychiatric illness among study groups 
 
 
 
 
 
 
52.50%
42.90%
31.40%
conservative treatment
hemodialysis
post renal transplantation
 Prevalence of various psychiatric illnes
Depressive disorder was present in 18 (38.3%) patients.  1 patient (2
had depressive disorder with psychotic symptoms, 3(6.4%) had anxiety disorder, 
15 (31.9%) had adjustment disorder, 7 (14.9%) had alcohol dependence 
syndrome, 3 (6.4%) had psychosis.
 
 
 
 
31.90%
14.90%
6.40%
56 
ses in chronic kidney disease
 
38.30%
2.10%
6.40%
depressive disorder
depression with psychotic 
symptoms
anxiety disorder
adjustment disorder
alcohol dependence syndrome
psychosis
 
.1%) 
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Presentation of psychiatric illnesses in patients with conservative treatment 
In conservative treatment group, 21 (52.5%) had psychiatric illness. 
Among these, 8(38.1%) had major depressive disorder, 1 (4.8%) had depressive 
disorder with psychotic symptoms, 1 (4.8%) had generalised anxiety disorder, 
4(19%) had adjustment disorder, 5(23.8%) had alcohol dependence syndrome and 
2 (9.5%) had psychosis.(Table - 4) 
 
 
 
 
38.1%
4.8%
19%
23.8%
9.5%
4.8%
0
5
10
15
20
25
30
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40
45
major 
depressive 
disorder
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disorder
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dependence 
syndrome
psychosis depression with 
psychotic 
symptoms
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Presentation of psychiatric illnesses in patients undergoing hemodialysis 
In hemodialysis group, 15 (42.9%) had psychiatric illness. Among these, 
5(33.3%) had major depressive disorder, 8(53.3%) had adjustment disorder and 
2(13.3%) had alcohol dependence syndrome. (Table - 4) 
 
 
 
 
 
33.3%
53.3%
13.3%
0
10
20
30
40
50
60
major depressive 
disorder
adjustment disorder alcohol dependence 
syndrome
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Presentation of psychiatric illnesses in post renal transplantation group 
In post renal transplantation group, 11 (31.4%) had psychiatric illness. 
Among these, 5(45.5%) had major depressive disorder, 2 (18.2%) had anxiety 
disorder, 3 (27.3%) had adjustment disorder, 1 (9%) had psychosis. Among 2 of 
the anxiety disorder patients one had illness anxiety and one had generalized 
anxiety disorder. (Table - 4) 
 
 
 
 
45.5%
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major depressive 
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Table - 4: Presentation of psychiatric illnesses among study population  
s.n Psychiatric illness Conservative treatment  
(n = 21) 
Hemodialysis 
(n = 15) 
Post renal transplantation 
(n = 11) 
1 Major depressive disorder  
n (%) 
8 (38.1) 5 (33.3) 5 (45.5) 
    Mild  1 0 1 
   Moderate  6 3 3 
   Severe  1 2 1 
Depression with psychotic 
symptoms 
1   
2 Anxiety disorder n(%) 1 (4.8)  2 (18.2) 
   Gen anxiety disorder 1  1 
  Illness anxiety   1 
3 Adjustment disorder 4 (19) 8 (53.3) 3 (27.3) 
    With anxiety symptoms   1 
    With depressive symptoms 4 8 2 
4 Alcohol dependence 
syndrome 
5 (23.8) 2 (13.3) 0 
 Mild 0 1 0 
 Moderate 2 1 0 
 Severe  3 0 0 
5 Psychosis 2 (9.5)  1 (9) 
6 Family history of psychiatric 
illness 
   
    Absent 33 (82.5) 29 (82.9) 29 (82.9) 
    Present 7 (17.5) 6 (17.1) 6 (17.1) 
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Treatment adherence among groups 
Overall, study population had high treatment adherence. 52.5% had high 
level of treatment adherence, 37.5% had medium level of adherence and 10% had 
low treatment adherence in conservative treatment. 57.1% had high treatment 
adherence, 31.4% had medium and 11.4% had low treatment adherence in 
hemodialysis treatment. In Post renal transplantation 74.3% had high, 22.9% had 
medium and 2.9% had low adherence with treatment. 
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10 11.4
2.9
0
10
20
30
40
50
60
70
80
conservative 
treatment
hemodialysis post renal 
transplantation
high adherence
medium adherence
low adherence
 Social support system among groups
 About 68.6% had high social support in post renal transplantation patients, 
but 45.7% of hemodialysis patients and 40% of patients in conservative group had 
high social support. 11.4%
conservative treatment respectively
 
 
    
 
0
10
20
30
40
50
60
70
conservative 
treatment
hemodialysis
22.5
11.4
37.5
40
62 
  
, 22.5% had low social support in hemodialysis and 
 
 
post renal 
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0
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Functional level of the patients among groups 
 All 35 (100%) patients in post renal transplantation are able to do normal 
activities as previously. Whereas only 75%, 65.7% patients able to carry on 
normal activities in conservative and hemodialysis treatment. About 17.1% were 
unable to carry on normal activity or to do active work in hemodialysis treatment. 
 
 
A – Able to carry on normal activity and to work; no special care needed 
B – Unable to work; able to live at home and care for most personal needs; 
varying amount of assistance needed 
C – Unable to care for self; requires equivalent of institutional or hospital care; 
disease may be progressing rapidly.  
75
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100
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40
60
80
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A
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Association between Socio-Demographic factors and Psychiatric illness in 
conservative treatment groups  
Among chronic kidney disease patients on conservative treatment, various 
socio-demographic factors collected during the study were analysed for their 
relationship with psychiatric illnesses. Chi square probability was used for this 
analysis. It was observed that patients from rural area had a statistically 
significant association with psychiatric illness. All other socio-demographic 
factors – gender, education, socio economic status, marital status, occupation and 
type of family did not reach statistical significance.(Table – 5) 
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Table - 5: Association between Socio-Demographic factors and Psychiatric 
illness in conservative treatment groups  
s.n  Socio demographic variables Psychiatric illnesses  P – value 
Absent 
(N=19) 
Present 
(N=21) 
1 sex Male 10 10 Chi square =  0.100 0.752 
female 9 11 
2 Education  Illiterate 2 4 Chi square = 1.644 0.439 
Primary level 8 11 
Secondary level 9 6 
Graduate 0 0 
Post graduate 0 0 
3 Socio economic status Upper 0 0 Chi square = 6.393 0.094 
Upper middle 2 0 
Lower middle 7 4 
Upper lower 8 9 
Lower  2 8 
4 Locality  Rural 0 4 Chi square = 4.021 0.045 
Urban  19 17 
5 Occupation  Unemployed  17 17 Chi square = 1.905 0.592 
Unskilled  2 2 
Semi skilled 0 1 
Skilled  0 1 
Profession  0 0 
6 Marital status Single 0 0 Chi square = 0.043 0.835 
Married  15 16 
Separated  4 5 
7 Family type Nuclear  14 17 Chi square = 0.302 0.583 
Joint  5 4 
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Association between socio demographic factors and psychiatric illness in 
hemodialysis patients 
In hemodialysis group, patients from rural area had statistical significance 
with psychiatric illness (chi square value = 9.655; P = 0.003). Statistical 
significance was also found with patients from joint family and presence of 
psychiatric illness (chi square = 9.655; P = 0.002). No other variables had 
statistical significance with psychiatric illness.(Table-6) 
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Table - 6: Association between socio demographic factors and psychiatric 
illness in hemodialysis patients 
s.n  Socio demographic variables Psychiatric illnesses  P – value 
Absent 
N = 20 
Present 
N = 15 
1 sex Male 9 11 Chi square =  2.810 0.091 
female 11 4 
2 Education  Illiterate 0 1 Chi square = 9.204 0.27 
Primary level 8 4 
Secondary level 8 6 
Graduate 4 4 
Post graduate 0 0 
3 Socio economic status Upper 0 0 Chi square = 10.840 0.13 
Upper middle 0 2 
Lower middle 9 0 
Upper lower 5 7 
Lower  6 6 
4 Locality  Rural 0 6 Chi square = 9.655 0.003 
Urban  20 9 
5 Occupation  Unemployed  17 9 Chi square = 8.249 0.083 
Unskilled  0 2 
Semi skilled 2 0 
Skilled  1 2 
Profession  0 2 
6 Marital status Single 4 2 Chi square = 0.319 0.853 
Married  14 11 
Separated  2 2 
7 Family type Nuclear  20 9 Chi square = 9.655 0.002 
Joint  0 6 
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Associations between socio demographic variables and psychiatric illness in 
post renal transplantation 
No statistical significance was observed between various socio 
demographic factors and presence of psychiatric illness in post renal 
transplantation patients. (Table-7) 
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Table - 7: Associations between socio demographic variables and psychiatric 
illness in post renal transplantation 
s.n  Socio demographic variables Psychiatric illnesses  P – value 
Absent 
N = 24 
Present 
N = 11 
1 sex Male 15 5 Chi square = 0.895  0.281 
female 9 6 
2 Education  Illiterate 0 1 Chi square = 3.700 0.296 
Primary level 3 0 
Secondary level 14 6 
Graduate 7 4 
Post graduate 0 0 
3 Socio economic status Upper 0 0 Chi square = 5.999 0.112 
Upper middle 7 0 
Lower middle 7 7 
Upper lower 9 3 
Lower  1 1 
4 Locality  Rural 8 2 Chi square = 0.441 0.309 
Urban  16 9 
5 Occupation  Unemployed  8 7 Chi square = 4.265 0.371 
Unskilled  6 1 
Semi skilled 5 1 
Skilled  3 2 
Profession  2 0 
6 Marital status Single 6 2 Chi square = 0.199 0.656 
Married  18 9 
Separated  0 0 
7 Family type Nuclear  17 9 Chi square = 0.476 0.490 
Joint  7 2 
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Chronic kidney disease related factors and presence of psychiatric illness 
 No statistically significant association was observed in the analysis of 
chronic kidney disease related factors (cause of renal disease, age at diagnosis, 
duration of treatment, co morbidity) and presence of psychiatric illness. No 
association was also observed with positive family history of psychiatric illness 
and presence of psychiatric illness in this study group.(Table - 8) 
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Table – 8: Chronic kidney disease related factors and presence of psychiatric 
illness 
s.n Illness related factors Psychiatric illness  P value 
  Present  
N = 47 
Absent  
N = 63 
  
1 Cause of renal failure    
 
 
 
6.984 
 
 
 
 
0.072 
Diabetes mellitus 2 10 
Systemic hypertension 18 19 
DM + SHT 8 4 
Others  19 30 
2 Age at diagnosis of CKD(mean years)     
Conservative treatment  54.76± 
9.428 
55.47 ± 
8.897 
T test = 0.245 0.411 
Haemodialysis treatment 39.60 ± 
15.389 
38.80 ± 
14.533 
T test = -.157 0.678 
 Post Renal transplantation 26.36 ± 
8.571 
29.08 ± 
10.138 
T test = 0.771 0.584 
3 Duration of treatment (mean years + s.d) 4 ± 2.368 4.02 ± 2.479 0.034 0.996 
4 Co morbid medical illness     
Present  17 15 Pearson chi square test = 
1.994 
0.158 
Absent  30 48 
5 Family h/o psychiatric illness     
Conservative 
treatment 
Present 7 0 7.677 0.006 
Absent 14 19 
Hemodialysis  Present 4 2 1.676 0.195 
Absent  11 18 
Post renal 
transplantation 
Present  2 4 0.012 0.812 
Absent  9 20 
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Association between psychiatric illness and support system in chronic kidney 
disease 
In the analysis of support system and psychiatric illness, patients with low 
support system had statistical significance with presence of psychiatric illness in 
conservative treatment (chi square = 9.969; P = 0.007) and hemodialysis 
treatment (chi square = 6.076; P = 0.048). In renal transplantation, majority of the 
patients had high support system and had lower prevalence of psychiatric illness 
(chi square = 12.696; P = 0.000) (Table – 9) 
Table – 9: Association between psychiatric illness and support system in 
chronic kidney disease 
s.n Treatment  Psychiatric illness Multidimentional scale of 
perceived social support 
 P value 
Low medium high 
1 Conservative 
treatment (N=40) 
Present (n=21) 8 9 4 9.969 0.007 
Absent (n=19) 1 6 12 
2 Hemodialysis  
(N= 35) 
Present (n=15) 4 5 6 6.076 0.048 
Absent (n=20) 0 10 10 
3 Renal 
transplantation 
(N=35) 
Present (n=11) 0 8 3 12.696 0.000 
Absent (n=24) 0 3 21 
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Association between psychiatric illness and functional ability of patients with 
chronic kidney disease 
In the analysis of functional ability using Karnofsky’s performance scale, 
patients unable to care for self and requires equivalent of institutional or hospital 
care had statistically significant association with presence of psychiatric illness in 
hemodialysis treatment patients. (chi square = 6.121; P = 0.047). No statistical 
variations observed with functional ability in conservative, renal transplanted 
patients with presence of psychiatric illness.(Table - 10) 
Table - 10: Association between psychiatric illness and functional ability of 
patients with chronic kidney disease 
s.
n 
Treatment  Psychiatric 
illness 
Karnofsky’s performance 
scale 
 P value 
A B C 
1 Conservative 
treatment (N=40) 
Present (n=21) 15 6 0 0.301 0.583 
Absent (n=19) 15 4 0 
2 Hemodialysis  
(N=35) 
Present (n=15) 5 4 6 6.121 0.047 
Absent (n=20) 12 8 0 
3 Renal 
transplantation 
(N=35) 
Present (n=11) 11 0 0   
Absent (n=24) 24 0 0 
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Association between psychiatric illness and cognitive functioning in chronic 
kidney disease  
In the analysis of cognitive functioning and presence of psychiatric analysis no 
statistically significant association was observed.(Table - 11) 
Table – 11:Association between psychiatric illness and cognitive functioning 
in chronic kidney disease  
s.
n 
Treatment  Psychiatric 
illness 
Montreal cognitive 
assessment scale 
Chi 
square 
test 
P value 
Score ≥ 26 Score < 26 
1 Conservative 
treatment (N=40) 
Present (n=21) 2 19 1.905 0.168 
Absent (n=19) 0 19 
2 Hemodialysis 
(N=35) 
Present (n=15) 7 8 1.033 0.114 
Absent (n=20) 11 9 
3 Renal 
transplantation 
(N=35) 
Present (n=11) 7 4 2.076 0.150 
Absent (n=24) 9 15 
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Association between psychiatric illness and treatment adherence in chronic 
kidney disease 
In the analysis of treatment adherence using Morisky’s medication adherence 
scale – 4,  presence of psychiatric illnesses  were associated with low treatment 
adherence in both conservative and hemodialysis group, but  it is statistically 
significant in hemodialysis group.(Table - 12) 
Table – 12: Association between psychiatric illness and treatment adherence 
in chronic kidney disease 
s.
n 
Treatment  Psychiatric 
illness 
Morisky medication 
adherence scale 4 
Chi 
square 
test 
P value 
High  Medium  Low  
1 Conservative 
treatment (N=40) 
Present (n=21) 9 8 4 4.406 0.110 
Absent (n=19) 12 7 0 
2 Hemodialysis 
(N=35)  
Present (n=15) 7 4 4 6.027 0.049 
Absent (n=20) 13 7 0 
3 Renal 
transplantation 
(N=35) 
Present (n=11) 8 3 0 0.600 0.742 
Absent (n=24) 18 5 1 
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DISCUSSION 
The study population was 110 chronic kidney disease patients. Of these 
36.4% were in conservative treatment, 31.8% were in hemodialysis, 31.8% were 
in post renal transplantation treatment. Among them, 42.7% had psychiatric 
illness. 
Conservative treatment 
Among the patients in conservative treatment, no difference was observed 
with gender. Majority were (55%) more than 60 years of age, belongs to upper 
lower socio economic status (42.5%), from urban background (90%) and 85% 
were unemployed. Majority were married (77.5%) and from nuclear family 
(77.5%). Mean age of renal disease diagnosis was 55.10 ± 9.06 years, the most 
common reported cause for renal disease was systemic hypertension (32.5%), 
about 42.5% were in stage 3, 57.5% were on treatment for more than 2 years and 
52.5% had at least one medical comorbidity. These findings were similar with C. 
P. Andrade (2012) et al., study. 
52.5% had psychiatric illness in conservative treatment. Most common was 
major depressive disorder 38.1%, results consistent with C. P. Andrade et al 
(2012) study, who observed 37.3% major depressive disorder in CKD patients 
with conservative treatment. 23.8% had alcohol dependence syndrome, 19% had 
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adjustment disorder, 9.5% had psychosis, 4.8% had generalized anxiety disorder, 
and 4.8% had major depression with psychotic symptoms. Among patients 
undergoing conservative treatment, psychiatric illness was not statistically related 
to socio demographic factors and chronic kidney disease related factors except for 
locality. 
52.5% had high level of treatment adherence, 37.5% with medium and 10% 
with low adherence. Presence of psychiatric illness was high with low and 
medium treatment adherence but results were not statistically significant. 22.5% 
had low support system, low and medium support system was statistically 
associated with presence of psychiatric illnesses. High support system was 
associated with absence of psychiatric illness, suggesting support system had an 
association with psychiatric illness either as a cause or as an effect.  
75% were able to carry on with their normal activities as previously. In this 
study presence or absence of psychiatric illness had no influence over functional 
ability or vice versa among conservative treatment. This is in variance with C. P. 
Andrade et al (2012) study, who observed psychiatric illness was associated with 
worst functional capacity. 
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Hemodialysis treatment 
Among the patients in hemodialyis treatment, 57.1% were males and 
42.9% were females; 51.4% were in the age group of 18 – 39 years. Patients with 
hemodialysis were younger than patients in conservative treatment. Majority   
belonged to upper lower (34.3%) and lower (34.3%) socio economic status and 
from urban background (82.9%). About 74.3% were unemployed, 71.4% were 
married and 82.9% were from nuclear family. Our study socio demographic 
variables results were similar to previous studies (Vikhram Ramasubramanian et 
al., 2015%, C. P. Andrade et al.,2012) except the age of presentation was earlier 
in our study group.  
Mean age of study population was 42.31 ± 15 years. Chronic renal disease 
diagnosed by 39.14 ± 14.7 years. In this study the most common cause of renal 
failure among hemodialysis patients was systemic hypertension (37.1%). All were 
in stage 5 chronic kidney disease.51.4% had treatment for less than a year, 42.9% 
had treatment for about 1 -2 years. 77.1% had comorbid medical illnesses. 
42.9% (n = 15) patients in hemodialysis had psychiatric illness. This is 
consistent with the findings of Vikhram Ramasubramanian et al., 2015, who 
observed 40% prevalence of psychiatric illness among hemodialysis patients. 
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 Most common psychiatric disorder observed was major depressive 
disorder (45.5%). This is consistent with previous study findings  Ossareh S et al 
(2014) – 42.7%, C. P. Andrade et al (2012) – 41.6% of major depressive disorder, 
Bossola et al (2010) – 52.5%, Montinaro et al (2010) – 50%, Keskin et al (2011) 
– 40.2%, Jadhav B S et al(2014) – 40.69%. 
 In this study among patients undergoing hemodialyis, 27.3% had 
adjustment disorder. This is in variance with Vikhram Ramasubramanian et al., 
2015 study  (10% had adjustment disorder) and Jadhav B S et al., 2014 study 
(49.9% had adjustment disorder).  
In this study 18.2% had anxiety disorder. Though Chen et al (2010) 
observed 21% of anxiety disorder, some of the previous studies reported high 
prevalence  (45.7% observed by Cukor et al., 2008; 35% observed by Taskapan et 
al., 2005; 43% observed by Montinaro et al.,2010) . in our study 9% had alcohol 
dependence. No statistical significance was observed with presence of psychiatric 
illness and socio demographic factors, chronic kidney disease related factors 
except for locality, type of family. Presence of psychiatric illness was more in 
patients from rural area (chi square = 9.655; P = 0.003). Joint family type was 
significantly associated with presence of psychiatric illness (chi square = 9.655; P 
= 0.002). 
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Patients in hemodialysis treatment, 57.1% had high treatment adherence, 
31.4% had medium adherence and 11.4% had low treatment adherence. About 
42.9% ( n= 15) had psychiatric illness, among them 26.7% ( n = 4) had low 
treatment adherence, 26.7% ( n = 4)  had medium treatment adherence and 46.7% 
( n = 7) had high treatment adherence. Whereas in patients with absence of 
psychiatric illness, none where in low treatment adherence, 35% (n = 7) were in 
medium treatment adherence and 65% ( n = 13) were in high treatment 
adherence. Our study results had showed statistically significant association 
between psychiatric illness and treatment adherence (chi square = 6.027; P = 
0.049) in hemodialysis group. These results go along with Ossareh S et al (2014), 
Cukor d et al (2009) study results. 
Among the patients undergoing hemodialysis, 45.7% had high support 
system, 42.9% had medium support and 11.4% had low social support. About 
42.9% (n = 15) had psychiatric illness, among them 26.7% ( n = 4) had low 
support, 33.3% ( n = 5) had medium support and 40% ( n = 6) had high support 
system. But in patients with absence of psychiatric illness – none had low 
support, 50% (n = 10) had medium support and 50% (n = 10) had high support 
system. This findings suggest statistically significant association between 
presence of psychiatric illness and low support system in patients undergoing 
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hemodialysis ( chi square = 6.076; P = 0.048). This results were consistent with 
previous study done by  Tezel A et al (2011). 
48.6% patients undergoing hemodialysis were able to carry on with their 
normal activities as previously, 34.3% patients were unable to work but were able 
to live at home and care for most of their personal needs, 17.1% were unable to 
care for self, requires equivalent of hospital care. This can be explained as 
patients undergoing hemodialysis were in stage 5, severe end stage renal disease, 
undergoing dialysis 2 -3 times/week interferes with their functional ability. In 
observation with presence of psychiatric illness, 5 were able to carry out normal 
activities, 4 were unable to work but able to care for self and 6 were unable to 
care for self, requires equivalent of hospital care at home.  In patients with 
absence of psychiatric illness 12 were able to carry their normal activities and 8 
were unable to work but able to care for self. In this study statistical significance 
was observed with presence of psychiatric illness and low functional ability in 
patients undergoing hemodialysis ( chi square = 6.121; P = 0.047). This finding is 
similar with C. P. Andrade  et al (2012), who observed presence of psychiatric 
illness was associated with worse functional capacity in patients undergoing 
hemodialysis. Kalender et al., (2006)also indicated the association between 
depression and functional capacity and classified this association as one of the 
risk factors for mortality in dialysis patients. 
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Post renal transplantation 
Among the patients in post renal transplantation treatment, mean age of 
study population was 33.51 ± 9.92 years. Mean age of renal disease diagnosis was 
28.23 ± 9.632 years, most common cause for renal failure was systemic 
hypertension (31.4%). Prior to transplantation all were in stage 5 and post 
transplantation about 5.7% were in stage 2 renal failure. Mean serum creatinine 
level was 1.51 ± 0.780. Majority  (91.4%) had undergone cadaver kidney 
transplantation. About 45.7% were in post renal transplantation treatment for 
more than 2 years. About 14.3% had medical comorbidity. 
In this study 31.4% had psychiatric illness in post renal transplantation 
treatment. Among this 31.4% of patients with psychiatric illness - 45.5% had 
major depressive disorder, 27.3% had adjustment disorder, 9.1% had generalized 
anxiety disorder, 9.1% had illness anxiety disorder and 9% had psychosis. 
Whereas, in a study done by Kalman T P (1983)et al reported 46% of patients had 
psychiatric illness and study done by Pawar A A et al(2006) reported 56.7% 
major depressive disorder in post renal transplantation patients. 
 No statistical significance was observed with presence of psychiatric 
illness and socio demographic factors. In this study no chronic kidney disease 
related factors were statistically associated with presence of psychiatric illness. 
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In post renal transplantation group, about 74.3% had high treatment 
adherence, 22.9% had medium treatment adherence and 2.9% had low adherence. 
No statistical significance was observed with treatment adherence and presence or 
absence of psychiatric illness (chi square = 0.600; P = 0.742). 68.6% had high 
social support, 31.4% had medium support systems, no one was in low social 
support group. Among 11 patients with psychiatric illness, 3 were in high support 
group and 8 were in medium support group. Whereas in 24 patients with no 
psychiatric illness 21 were in high support system and 3 were in medium support 
system. Presence of psychiatric illness is associated with medium support system 
and absence of psychiatric illness is associated with high support system. This 
results were also statistically significant (chi square = 12.696; P = 0.000). All 
patients (100%) in post renal transplantation were able to carry their normal 
activity as that of premorbid level. 
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CONCLUSION 
In this study, comparatively more young patients were in renal 
transplantation and hemodialysis treatment, whereas in conservative treatment 
majority were elder patients. Gender distribution was equal in all 3 groups. 
Comparatively patients in hemodialysis, renal transplantation were better 
educated than patients in conservative treatment. Regarding socio economic 
status, in conservative group and hemodialysis majority were in low socio 
economic status but in renal transplantation majority  belonged to middle socio 
economic state. In all three groups majority were residing in urban area. In 
conservative treatment about 3/4th was unemployed, considering age factor in 
conservative treatment unemployment can be explained. But in hemodialysis 
majority were in middle age adults and among them about 3/4th were 
unemployed. In renal transplantation more than half of the study populations were 
employed. In all three groups majority were belonging to nuclear family. The 
most common cause for renal failure was systemic hypertension in all three 
groups. Glomerulonephritis also contributed significantly in hemodialysis and 
post renal transplantation patients. Medical comorbidity was more prevalent in 
patients on conservative treatment and hemodialysis than in post renal 
transplantation. 
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In this study, presence of psychiatric illnesses were high in conservative treatment 
(52.5%) than in patients undergoing hemodialysis (42.9%) than in patients in post 
renal transplantation (31.4%). Among the psychiatric illnesses major depressive 
disorder was the most common in all three groups. Family history of psychiatric 
illness had no correlation with presence of psychiatric illness. Treatment 
adherence, social support system and functional ability were better for patients on 
post renal transplantation than conservative treatment and hemodialysis. 
To summarize 
Statistically significant associations were observed between following variables 
in this study 
1) Rural locality and presence of psychiatric illness in conservative treatment 
group 
2) Joint family and presence of psychiatric illness in hemodialysis group 
3) Low support system and presence of psychiatric illness in all three groups 
4) Low functional ability and presence of psychiatric illness in hemodialysis 
group 
5) Low treatment adherence and presence of psychiatric illness in hemodialysis 
group. 
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A high prevalence of psychiatric illnesses in patients with chronic kidney disease 
(42.7%) has been observed in this study and also in previous studies. Presence of 
psychiatric illnesses among chronic kidney disease is associated with low 
treatment adherence and reduced functional ability. Hence it becomes obvious 
that the presence of psychiatric illnesses in chronic kidney disease need to be 
effectively identified and managed 
An effective liaison services between the physicians treating chronic kidney 
disease and psychiatric services can improve the outcome of chronic kidney 
disease and thereby improve the quality of life of patients with chronic kidney 
disease. 
Limitations of the study 
This study is a cross sectional observation study. Analytical study may 
provide more information regarding presence of psychiatric illnesses, social 
support system, treatment adherence and functional ability among various 
treatment groups.  
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ANNEXURE   
INFORMED CONSENT FORM 
STUDY: “Psychiatric morbidity in patients with Chronic Kidney 
Disease: a cross sectional study”. 
STUDY CENTRE: Department of Nephrology, Govt. Kilpauk Medical 
College Hospital. 
PATIENT’S NAME : 
PATIENT’S AGE : 
I.P NO.   : 
Patient may check ( ) these boxes 
I confirm that I understood the purpose of the procedure for the above 
study.          ( ) 
I had the opportunity to ask question and all my questions and doubts have 
been answered to my complete satisfaction.    ( ) 
I understand that my participation in the study is voluntary and that I am 
free to withdraw at any time without giving reason, without my legal rights 
being affected.         ( ) 
I understand that the ethical committee members  and the regulatory 
authorities will not need my permission to look at my health records, both 
in respect of the current study and any further research that may be 
conducted in relation to it, even if I withdraw from the study I agree to this 
access.           ( ) 
However, I understand that my identity will not be revealed in any 
information released to third parties or published, unless as required under 
the law.          ( ) 
I agree not to restrict the use of any data or results that arise from the 
study.          ( ) 
I agree to take part in the above study and to comply with the instructions 
given during the study and faithfully co-operate with the study team and to 
immediately inform the study staff if I suffer from any deterioration in my 
health or well being or any unexpected or unusual symptoms.( ) 
I hereby consent to participate in this study.    ( ) 
I hereby give permission to undergo complete clinical examination and 
diagnostic tests including hematological, biochemical, radiological tests. 
           ( ) 
 
 
Signature / thumb impression 
Patient’s name and address: 
 
 
Place: 
Date: 
 
 
Signature of the investigator: 
Study investigator’s name: 
Place: 
Date: 
PARTICIPANTS' INFORMATION SHEET 
 
Investigator   : Dr. M. Tamilselvi 
Name of the participant :  
 
Study title: “Psychiatric morbidity in patients with Chronic Kidney 
Disease: a cross sectional study”. 
 
 You are invited to take part in this research study. We have got 
approval from the IEC. You are asked to participate because you satisfy the 
eligibility criteria. 
 
What is the purpose of this research? 
 In this study, we aim to assess the prevalence of psychiatric illnesses 
in patients with Chronic Kidney Disease, the association between 
psychiatric comorbidity and different sociodemographic factors and 
disease related factors, to assess the relationship between psychiatric 
comorbidity and support system, functional level, treatment adherence. 
This will help in assessing the burden of psychiatric illnesses in people 
with chronic kidney disease and how it affects the outcome of illness, so 
that earlier detection and treatment of psychiatric illnesses may improve 
the outcome of chronic kidney disease.  
Benefits: 
 This study will benefit all people who are undergoing treatment for 
chronic kidney disease and help improve the success rate of chronic 
kidney disease treatment, and also improves their quality of life. 
Discomforts and risks: 
 No interventional procedure is done in this study. 
Confidentiality: 
 Patients who participate in the study and their details will be 
maintained confidentially and at any cost, those details will not be let out. 
 
Right to withdraw: 
Patients  will not be forced to complete the study. At any cost, in such 
circumstances the treatment  will not be compromised. 
 
 
 
Signature/Thumb impression of  the participant: 
 
 
Signature of the investigator: 
 
Date : 
Place: 
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 ஆவ1 பய9ப-தி( ெகாள, 
அைத ப1ர2(க எ9 ;I மன6ட9 சமதி(கிேற9.  
 ( ) 
இAத ஆவ1 ப:) ெகாள ஒ(ெகாகிேற9. என()( 
ெகா(கபட அறிைரகள%9 ப
 நடA6ெகாவ6ட9, இAத 
ஆைவ ேமBெகாF ம'-6வ அண1() உ=ைமHட9 
இ'ேப9 எ9 உதியள%(கிேற9. எ9 உட நல 
பாதி(கபடாேலா அல6 எதி$பாராத வழ(க-திB) மாறாக 
ேநா()றி ெத9படாேலா உடேன அைத ம'-6வ அண1ய1ட 
ெத2வ1ேப9 என உதி அள%(கிேற9.      
       ( ) 
இAத ஆவ1 என() ம'-6வ ப2ேசாதைன ெச6 ெகாள 
மB ஆவ1 ப:ேகBக நா9 ;I மன6ட9 சமதி(கிேற9. 
            ( ) 
ப:ேகBபவ29 ைகெயாப / கைடவ1ர ேரைக:  
 
___________________ 
இட: ____________________________ 
ேததி: _____________________________ 
ப:ேகBபவ29 ெபய$ மB வ1லாச:: 
 
ஆவாள29 ைகெயாப _________________________ 
இட _________________________ 
ேததி __________________________ 
ஆவாள29 ெபய$ ____________________________
ஆரா.சி தகவ தா 
 கி5பா(க அர ெபா6 ம'-6வமைனய1 நாபட 
சிநரக ேநா உளவ$கள%ட இ'() மனேநாகைள( 
)றி-6 ஆரா.சி ெசய உேளா.  ந:க இAத ஆரா.சிய1 
ப:ேகBக நா:க வ1'கிேறா. இAத ஆரா.சிய1 
ப:ேகBபதா த:கள6 ேநாய19 ஆவறி(ைகேயா அல6 
சிகி.ைசேயா பாதி(கபடா6 எ9பைதH ெத2வ1-6( 
ெகாகிேறா. 
 இAத ஆரா.சிய19 ;
கைள அல6 க'-6கைள 
ெவள%ய1 ேபாேதா அல6 ஆரா.சிய19 ேபாேதா த:கள6 
ெபயைரேயா அல6 அைடயாள:கைளேயா ெவள%ய1டமாேடா 
எ9பைதH ெத2வ1-6( ெகாகிேறா. 
 இAத ஆரா.சிய1 ப:ேகBப6 த:கFைடய வ1'ப-தி9 
ேப2 தா9 இ'(கிற6. ேமE ந:க எAேநர; இAத 
ஆரா.சிய1 இ'A6 ப19வா:கலா எ9பைதH 
ெத2வ1-6(ெகாகிேறா. 
 இAத சிற ப2ேசாதைனகள%9 ;
கைள ஆரா.சிய19 
ேபாேதா அல6 ஆரா.சிய19 ;
வ19 ேபாேதா த:கF() 
அறிவ1ேபா எ9பைதH ெத2வ1-6(ேகாகிேறா.  
 
ஆரா.சியாள$ ைகெயாப  ப:ேகBபாள$ ைகெயாப 
ேததி: 
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